A Pharmaceutical entity from India is looking for strategic investment opportunities in API and Formulation entities in India.

Posted By - Investment Banker

TARGET BRIEF

A pharmaceutical client is looking out for acquiring a GMP / MHRA approved/certified Formulation plant having a capacity of approx 200-250 MT per month and an API plant having capacity of producing volume building API’s ( paracetamol, ibuprofen, Metformin) of around 300 – 500 MT per month anywhere in India. The firm has established world-class manufacturing facilities by leveraging state-of-the-art technology, incorporating best practices and adhering to stringent regulatory compliance. The Plants are approved by prestigious US FDA, UK MHRA, Australian TGA and other foreign health authorities. R&D capabilities include dossier development, chemical synthesis, process optimization, formulation development, analytical development.

Proposal

Dealsize IconDeal Size INR 1000 to 2000 Mn
Special Requirement: Tablets and Capsules capacity
Industry Icon

Industry

Pharmaceuticals

Subindustry Icon

Sub-Industry

Integrated

Target Location

12, 9, 14, 15, 33, 16, 1, 17, 6, 4, 18, 19, 20, 10, 21, 7, 2, 22, 23, 24, 25, 26, 5, 3, 31, 30, 29, 28, 13, 8, 27

Type

General & Beta Lactum

Product

paracetamol, ibuprofen, Metformin

Export

Yes

Formulation type

Oral Solids, Liquids, Parenteral

Type

Branded

Therapeutic Area

Chronic, Acute

Funding Sources

Cash,Fresh Debt

Synergies Sought

Manufacturing Strengths (Production/Operations)

Deal Option

Complete Buyout

Open For Distressed Assets

Business Operating Information

Industry Icon Industry: Pharmaceuticals

Industry Icon Sub-Industry: Bulk Drug manufacturing

Division

Division`s Buyers/Customers

Division`s Plant Location

Financial Information

2018 (in INR) 2019 (in INR) 2020 (in INR) 2021 (in INR)
Sales 9210 Mn 10046 Mn N.D N.D
EBDITA N.D N.D
PAT N.D N.D
TANGIBLE NET WORTH N.D N.D
LONG TERM DEBT N.D N.D N.D N.D
TOTAL DEBT N.D N.D
CONTACT BUSINESS

If you are interested in connecting with business please send an Expression of Interest.

SHARE VIA
CONTACT DETAILS